Barkby Group PLC has today provided an update on trading for the 26 weeks ended 30 December 2021, with highlights from our Real Estate, Investments and Pub businesses.
View the announcement here: https://t.co/SpoufushTp
“Collaboration has always been at the heart of our business & we are looking forward to a successful year working with all of our partners to play a role in addressing the global sleep challenge”.
View the announcement here: https://t.co/3vVCE6RAj7
We are pleased to announce that our subsidiary, Cambridge Sleep Sciences, has developed more than 10 new sales partnerships as part of its continued growth strategy.
https://t.co/3vVCE6RAj7
Dr. Julian Stone (@sleep_ceo), CEO of CSS, said: “I’m delighted to be partnering with these leading household names as we continue to extend the reach of @My_SleepHub® in our key markets”.
Verso Biosense, one of our investment companies, has announced its micro-sensing device, Usense, has been well received by patients in initial trials.
https://t.co/IuEqQoBUMg
Professor Ying Cheong, Reproductive Medicine Specialist at University Hospital Southampton commented:
“This wireless implant could revolutionise fertility care across the NHS and internationally & improve the chance of conceiving for many women.”
We’re pleased to announce that we have exchanged contracts on a property development site in Swindon, Wiltshire, with the intention of developing a 30,000 sq. ft. mixed-use retail and trade scheme at the site.
https://t.co/yxwsvqPhak
“The site is well positioned and we are pleased that we are once again seeing strong demand from both the retail and employment sectors for new, well-located developments, despite the wider economic impact of the pandemic.”
Charles Dickson, Chairman of Barkby, commented: We look forward to the future with confidence, knowing that we have a highly diversified business with significant growth opportunities."
The Barkby Group PLC has today provided an update on trading for the 12-month period ending 30 June 2021, with operational highlights from its Commercial Property, Hospitality and Consumer and Life Sciences divisions.
View the update here: https://t.co/2p7Ri1iaYq
Charles Dickson, Chairman of Barkby, commented: “I am delighted to add The Ebrington Arms to our exceptional portfolio of award winning pubs with accommodation...I very much welcome them into the Barkby Group.”
We are delighted to announce that Barkby Hospitality has entered a new 6 year leasehold agreement for The Ebrington Arms, in Ebrington, Gloucestershire. Holder of 2 AA Rosettes, they’ve been rated @thetimes’ 'number 1 UK village pub' & home to 'UK Pub for Food' by @Telegraph.
Our subsidiary Cambridge Sleep Sciences, the science-based sleep technology business behind @My_SleepHub, has announced new partnerships with Probitas Technologies, Nexus Digital Technology & My Benefits World as part of its continued growth strategy.
https://t.co/VosEdBuaAq
Joseph continues: “We are moving at pace to provide our monitoring platform to meet the needs of patients and we are delighted by the progress that we are making.”
We are pleased to announce that Verso Biosense, an innovator in UK femtech focused on improving women’s health, has signed a collaboration agreement with one of the UK’s leading fertility clinics, London Women’s Clinic.
View the announcement here: https://t.co/7focytWsZ8
Joseph Cefai, Head of Product Development at Verso Biosense, adds: “It is testament to the potential of our ground-breaking platform that this is the 2nd partnership we’ve announced in the space of a few weeks, following our agreement with Homerton University Hospital in March”.